51.2003 Pharmaceutics and Drug Design
A program that focuses on the scientific study of the formulation of medicinal substances into product vehicles capable of being stored, transported, and then introduced into the patient and behaving in ways optimal to therapeutic interaction. Includes instruction in statistics, biopharmaceutics, drug metabolism, pharmacokinetics, pharmacodynamics, physical pharmacy, pharmacological analysis, drug design and development, pharmacological biotechnology, chemical separations, spectroscopy, drug-host interactions, immunology, quantitative drug measurement, enzymatic transformations, and metabolic excretion.
Where 51.2003 sits in the CIP 2020 hierarchy
- >51 HEALTH PROFESSIONS AND RELATED PROGRAMS
- >>51.20 Pharmacy, Pharmaceutical Sciences, and Administration
- >>>51.2003 Pharmaceutics and Drug Design
- >>>51.2003 Pharmaceutics and Drug Design
51.2003 in other classification systems
Equivalent and related codes across 2 other systems. Click any code to see its full definition, hierarchy, and crosswalks.
Other CIP 2020 codes under 51.2003 Pharmaceutics and Drug Design
- 51.2001Pharmacy
- 51.2002Pharmacy Administration and Pharmacy Policy and Regulatory Affairs
- 51.2004Medicinal and Pharmaceutical Chemistry
- 51.2005Natural Products Chemistry and Pharmacognosy
- 51.2006Clinical and Industrial Drug Development
- 51.2007Pharmacoeconomics/Pharmaceutical Economics
- 51.2008Clinical, Hospital, and Managed Care Pharmacy
- 51.2009Industrial and Physical Pharmacy and Cosmetic Sciences
- 51.2010Pharmaceutical Sciences
- 51.2011Pharmaceutical Marketing and Management
- 51.2099Pharmacy, Pharmaceutical Sciences, and Administration, Other
Frequently asked questions
- What is CIP 2020 51.2003?
- CIP 2020 51.2003 is "Pharmaceutics and Drug Design". A program that focuses on the scientific study of the formulation of medicinal substances into product vehicles capable of being stored, transported, and then introduced into the patient and behaving in ways optimal to therapeutic interaction. Includes instruction in statistics, biopharmaceutics, drug metabolism, pharmacokinetics, pharmacodynamics, physical pharmacy, pharmacological analysis, drug design and development, pharmacological biotechnology, chemical separations, spectroscopy, drug-host interactions, immunology, quantitative drug measurement, enzymatic transformations, and metabolic excretion.
- How does CIP 2020 51.2003 map to other classification systems?
- 51.2003 Pharmaceutics and Drug Design has equivalents in SOC 2018 (19-1021, 19-1042, 25-1071); ISCED-F 2013 (0512). These crosswalks let you translate this code between CIP 2020 and 2 other classification systems.
- What is the parent category of 51.2003?
- 51.2003 Pharmaceutics and Drug Design sits under 51.2003 Pharmaceutics and Drug Design in the CIP 2020 hierarchy.
Classify my business
Describe your business in plain English and get matching codes across CIP 2020 and other major systems.
Interactive browser
Open 51.2003 in the full interactive explorer with tree view, search, and drill-downs.